Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Oncogene
  • Original Paper
  • Published:

Allelic deletion at 11q23 is common inMYCN single copy neuroblastomas

Oncogenevolume 18, pages4948–4957 (1999)Cite this article

Abstract

Deletions of the long arm of chromosome 11 (11q) have been noted in primary neuroblastomas, but a comprehensive analysis has not been performed. Therefore, we analysed 331 neuroblastomas (295 sporadic, 15 familial and 21 tumor-derived cell lines) to determine the prevalence of 11q allelic deletions, to map the location of a putative tumor suppressor gene and to perform clinical correlative studies. Assays for loss of heterozygosity (LOH) were performed at 24 microsatellite loci spanning 11q. LOH was observed at multiple 11q loci in 129/295 (44%) sporadic neuroblastomas, 5/15 (33%) familial neuroblastomas, and 5/21 (24%) neuroblastoma cell lines. A single region of 2.1 cM within 11q23.3, flanked by markersD11S1340 andD11S1299, was deleted in all specimens with 11q LOH. Allelic loss at 11q23 was inversely related toMYCN amplification (P<0.001). Within the subset of cases with a single copy ofMYCN, 11q LOH was associated with advanced stage disease (P=0.008), unfavorable histopathology (P=0.042), and decreased overall survival probability (P=0.008). However, 11q LOH was not independently prognostic in multivariate analyses. These data support the hypothesis that a tumor suppressor gene mapping within 11q23.3 is commonly inactivated during the malignant evolution of a large subset of neuroblastomas, especially those with unamplifiedMYCN.

This is a preview of subscription content,access via your institution

Access options

Access through your institution

Subscribe to this journal

Receive 50 print issues and online access

￥40,000 per year

only ￥800 per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Altura RA, Maris JM, Li H, Boyett JM, Brodeur GM and Look AT. . 1997Genes Chromosom. Cancer19: 176–184.

  • Bader SA, Fasching C, Brodeur GM and Stanbridge EJ. . 1991Cell Growth Differ.2: 245–255.

  • Baysal BE, van Schothorst EM, Farr JE, James MR, Devilee P and Richard CW 3rd. . 1997Genomics44: 214–221.

  • Biedler JL, Ross RA, Shanske S and Spengler BA. . 1980Advances in Neuroblastoma Research. Evans AE. (ed.).. Raven Press: New York pp. 81–96.

    Google Scholar 

  • Bown NP, Pearson AD and Reid MM. . 1993Cancer Genet. Cytogenet.69: 166–167.

  • Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F and Stoerkel S. . 1997J. Pathol.181: 394–400.

  • Brodeur G, Seeger RC, Schwab M, Varmus HE and Bishop JM. . 1984Science224: 1121–1124.

  • Brodeur GM and Castleberry RP. . 1997Principles and Practice of Pediatric Oncology. Pizzo PA and Poplack DG (eds).. Lippincott-Raven: Philadelphia, pp. 761–798.

    Google Scholar 

  • Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL and Tsiatis AA. . 1981Cancer Res.41: 4678–4686.

  • Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD and White PS. . 1997J. Pediatr. Hematol. Oncol.19: 93–101.

  • Brodeur GM, Sekhon GS and Goldstein MN. . 1977Cancer40: 2256–2263.

  • Caron H, van Sluis, P, Buschman R, Peteira do Tanque R, Maes P, Beks L, de Kraker J, Voute PA, Vergnaud G, Westerveld A, Slater R and Versteeg R. . 1996aHum. Genet.97: 834–837.

  • Caron H, van Sluis P, de Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA and Versteeg R. . 1996bNew Engl. J. Med.334: 225–230.

  • Cox DR. . 1972J. R. Stat. Soc. B34: 187–220.

  • Evans AE, D'Angio GJ and Randolph JA. . 1971Cancer27: 374–378.

  • Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT and Brodeur GM. . 1992Cancer Res.52: 1780–1785.

  • Gehring M, Berthold F, Edler L, Schwab M and Amler LC. . 1995Cancer Res.55: 5366–5369.

  • Hallstensson K, Thulin S, Aburatani H, Hippo Y and Martinsson T. . 1997Eur. J. Cancer32: 1966–1970.

  • Kaplan E and Meier P. . 1958J. Am. Stat. Assoc.53: 457–481.

  • Koiffmann CP, Gonzalez CH, Vianna-Morgante AM, Kim CA, Odone-Filho V and Wajntal A. . 1995Am. J. Med. Genet.58: 46–49.

  • Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A and Bown N. . 1997Genes Chromosom. Cancer18: 162–169.

  • Maris JM, Jensen SJ, Sulman EP, Beltinger CP, Gates K, Allen C, Biegel JA, Brodeur GM and White PS. . 1996Genomics35: 289–298.

  • Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ, Allen C, Biegel JA and Brodeur GM. . 1997Eur. J. Cancer33: 1923–1928.

  • Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT and Brodeur GM. . 1995Cancer Res.55: 4664–4669.

  • Martinsson T, Sjoberg RM, Hedborg F and Kogner P. . 1995Cancer Res.55: 5681–5686.

  • Mertens F, Johansson B and Mitelman F. . 1997Cancer Res.57: 2765–2780.

  • Moorhead PS and Evans AE. . 1980Prog. Cancer Res. Ther.12: 109–118.

  • Moss TJ, Reynolds CP, Sather HN, Romansky SG, Hammond GD and Seeger RC. . 1991New Engl. J. Med.324: 219–226.

  • Nowak NJ and Shows TB. . 1995Cancer Invest.13: 649–659.

  • Pegelow CH, Ebbin AJ, Powars D and Towner JW. . (1975).J. Pediatr.87: 763–765.

  • Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC and Feuerstein BG. . 1997Am. J. Pathol.150: 81–89.

  • Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tome P, Aggarwal A, Bajorek E, Bentolila S, Birren BB, Butler A, Castle AB, Chiannikulchai N, Chu A, Clee C, Cowles S, Day PJ, Dibling T, Drouot N, Dunham I, Duprat S, East C and Hudson TJ. . 1996Science274: 540–546.

  • Seeger RC, Wada R, Brodeur GM, Moss TJ, Bjork RL, Sousa L and Slamon DJ. . 1988Prog. Clin. Biol. Res.271: 41–49.

  • Shimada H, Chatten J, Newton Jr. W, Sachs N, Hamoudi AB, Chiba T, Marsden HB and Misugi K. . 1984J. Natl. Cancer Inst.73: 405–416.

  • Srivatsan ES, Ying KL and Seeger RC. . 1993Genes Chromosom. Cancer7: 32–37.

  • Takeda O, Handa M, Uehara T, Maseki N, Sakashita A, Sakurai M, Kanda N, Arai Y and Kaneko Y. . 1996Brit J. Cancer74: 1620–1626.

  • Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K and Yokota J. . 1995Oncogene11: 1829–1834.

  • Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K and Yokota J. . 1997Cancer Res.57: 907–912.

  • Van Gele M, Van Roy N, Jauch A, Laureys G, Benoit Y, Schelfhout V, De Potter CR, Brock P, Uyttebroeck A, Sciot R, Schuuring E, Versteeg R and Speleman F. . 1997Eur J. Cancer33: 1979–1982.

  • Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A and Speleman F. . 1998Genes Chromosom. Cancer23: 141–152.

  • White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S and Brodeur GM. . 1995Proc. Natl. Acad. Sci. USA92: 5520–5524.

  • Yuan B, Vaske D, Weber JL, Beck J and Sheffield VC. . 1997Am. J. Hum. Genet.60: 459–460.

Download references

Acknowledgements

The authors would like to thank the member institutions of the CCG for providing patient samples, Mr Richard Gallego for specimen processing, Mr David Blake for technical assistance and Dr CP Reynolds for providing some of the neuroblastoma cell lines. This work was supported by grants from the National Institutes of Health CA-13539 (Children's Cancer Group), CA-78545 and CA-78966 (JM Maris), CA-39771 (GM Brodeur), CA-60104 (RC Seeger), by funds provided through the Audrey E Evans Endowed Chair at the Children's Hospital of Philadelphia (GM Brodeur) and by Career Development Awards through the American Society of Clinical Oncology (JM Maris) and the American Cancer Society (JM Maris).

Author information

Authors and Affiliations

  1. Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, Pennsylvania, USA

    Chun Guo, Peter S White, Matthew J Weiss, Michael D Hogarty, Patricia M Thompson, Garrett M Brodeur & John M Maris

  2. Department of Pediatrics, University of Pennsylvania School of Medicine, PA 19104, Philadelphia, USA

    Garrett M Brodeur & John M Maris

  3. Children's Cancer Group, Arcadia, CA 91066, California, USA

    Peter S White, Michael D Hogarty, Daniel O Stram, Robert Gerbing, Katherine K Matthay, Robert C Seeger, Garrett M Brodeur & John M Maris

  4. Department of Pediatrics, University of Southern California School of Medicine, Los Angeles, CA 90027, California, USA

    Daniel O Stram & Robert C Seeger

  5. Department of Pediatrics, University of California at San Francisco School of Medicine, San Francisco, CA 94143, California, USA

    Katherine K Matthay

Authors
  1. Chun Guo

    You can also search for this author inPubMed Google Scholar

  2. Peter S White

    You can also search for this author inPubMed Google Scholar

  3. Matthew J Weiss

    You can also search for this author inPubMed Google Scholar

  4. Michael D Hogarty

    You can also search for this author inPubMed Google Scholar

  5. Patricia M Thompson

    You can also search for this author inPubMed Google Scholar

  6. Daniel O Stram

    You can also search for this author inPubMed Google Scholar

  7. Robert Gerbing

    You can also search for this author inPubMed Google Scholar

  8. Katherine K Matthay

    You can also search for this author inPubMed Google Scholar

  9. Robert C Seeger

    You can also search for this author inPubMed Google Scholar

  10. Garrett M Brodeur

    You can also search for this author inPubMed Google Scholar

  11. John M Maris

    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Guo, C., White, P., Weiss, M.et al. Allelic deletion at 11q23 is common inMYCN single copy neuroblastomas.Oncogene18, 4948–4957 (1999). https://doi.org/10.1038/sj.onc.1202887

Download citation

Keywords

Access through your institution
Buy or subscribe

Advertisement

Search

Advanced search

Quick links

[8]ページ先頭
©2009-2025 Movatter.jp